Brown & Brown, Inc. (BRO) Down 4.7% — Do I Admit Defeat and Sell?

  • BRO fell 4.65% to $68.10 from $71.42 the previous trading day
  • Weiss Ratings assigns C- (Hold)
  • Market cap is $23.90B with a dividend yield of 0.92%

Brown & Brown, Inc. (BRO) extended its recent slide on Tuesday, dropping 4.65% and shedding $3.32 to close at $68.10 on the NYSE. The session's decline keeps the stock well off its 52-week high of $96.55, reached on October 8, 2025 — BRO now sits approximately 29.5% below that peak, a gap that underscores how significantly sentiment has deteriorated over the past eleven months.

Volume came in at roughly 732,000 shares, a fraction of the 90-day average of approximately 2.84 million. That sharp shortfall between actual and average turnover suggests today's selling was not a broad-based capitulation event, but a persistent, low-conviction drift lower — the kind of quiet erosion that can be harder to reverse than a high-volume washout.


Why Brown & Brown, Inc. Price is Moving Lower

Tuesday's decline is rooted in unresolved concerns that surfaced with Brown & Brown's Q2 results reported on July 28, and subsequently compounded by an analyst downgrade. The headline numbers from Q2 looked passable at a glance — revenue still grew 30.4% year over year — but that figure was almost entirely acquisition-driven, courtesy of the Accession deal. Strip out that tailwind and the picture turns unflattering quickly: organic revenue excluding contingent commissions actually declined 0.7%. The company also missed on both top and bottom lines, posting adjusted EPS of $1.07 against the $1.08 consensus estimate and revenue of $1.68 billion against the $1.72 billion expected — a $40 million, or 2.3%, shortfall that the market has not yet forgiven.

Margin pressure adds another layer of concern. Adjusted EBITDAC margin fell to 35.7% in Q2, down 100 basis points from the prior year. The deterioration was steeper inside the Specialty Distribution segment, where organic revenue excluding contingents dropped 3.5% and the margin compressed 400 basis points to 42.7%. Management's own guidance offered little comfort: second-half Retail organic growth excluding contingents was projected at only 1.5% to 2.5%, with full-year adjusted EBITDAC margin expected to finish roughly flat. That combination — an organic growth miss, margin headwinds, and muted forward guidance — has kept sellers engaged well beyond the initial earnings reaction.

Morgan Stanley formalized the skepticism on July 6, cutting BRO to Underweight from Equalweight and reducing its price target to $55 from $60. The firm's concerns centered on slowing insurance pricing, the company's heavier-than-peers Florida property exposure, intensifying middle-market competition, and a worsening battle for producers and talent — structural pressures that don't resolve in a quarter or two. With no new catalyst expected until the next earnings report around October 26, today's selling reflects a market that is still repricing BRO for a slower-growth reality, not reacting to any fresh negative development.


What is the Brown & Brown, Inc. Rating - Should I Sell?

Weiss Ratings assigns BRO a C- rating. Current recommendation is Hold. That rating places the stock in cautious territory — not a name to exit in a panic, but equally not one to add to with conviction given the current fundamental backdrop.

The sub-index picture is mixed, with pockets of genuine strength sitting alongside meaningful areas of concern. Revenue growth of 32.43% earns a Good Growth Index, though investors should weight that figure carefully — the bulk of the expansion is acquisition-driven, with organic growth now in negative territory. A profit margin of 18.08% also contributes to a Good Efficiency Index, a respectable figure for an insurance brokerage operating in a competitive middle-market environment. The Excellent Solvency Index is a genuine bright spot, indicating the balance sheet carries manageable leverage even as the company has been active on the acquisition front.

Where the rating loses ground is on performance-oriented measures. The Weak Total Return Index reflects how badly the stock has lagged relative to expectations over the recent period — a 29.5% decline from the 52-week high is not a minor pullback for a Financials company of this profile. The Weak Volatility Index signals that BRO has been subject to sharp, disorderly price swings, which raises the risk profile for investors who cannot tolerate that kind of turbulence. ROE of 10.01% is functional but uninspiring, particularly for a brokerage business where capital efficiency should be a core competitive advantage.

Within the Financials sector, Brown & Brown ranks below Ping An Insurance (Group) Company of China, Ltd. (PNGAY, C+), The Progressive Corporation (PGR, C+), Marsh & McLennan Companies, Inc. (MRSH, C), and Arthur J. Gallagher & Co. (AJG, C), and is on par with Tokio Marine Holdings, Inc. (TKOMF, C-). That relative positioning reinforces the view that BRO is not among the more compelling risk-adjusted opportunities in the insurance brokerage space right now.


About Brown & Brown, Inc.

Brown & Brown, Inc. (BRO) is a Financials company and one of the largest independent insurance intermediaries in the United States. The company does not underwrite risk directly; instead, it earns commissions and fees by placing commercial and personal lines coverage on behalf of clients, acting as the intermediary between businesses, individuals, and the carriers that ultimately bear the risk. This asset-light, fee-driven model has historically generated strong cash flows and protected the business from underwriting losses during volatile catastrophe years.

Brown & Brown organizes its operations across four segments: Retail, National Programs, Wholesale Brokerage, and Services. The Retail segment serves small and mid-sized commercial clients and individual consumers with a broad range of property, casualty, employee benefits, and professional liability products. National Programs develops and manages specialty insurance programs for defined niche markets — from professional associations to specific industries — where deep expertise creates pricing and placement advantages that general brokers cannot easily replicate. The Wholesale Brokerage segment connects retail agents with specialty and surplus lines markets, while the Services segment provides claims management and other administrative solutions.

The company has built much of its scale through disciplined, decentralized acquisition activity, acquiring regional and specialty brokers and allowing them to retain local management and client relationships. That model has proven effective at compounding revenue over time, though it also means that headline growth figures can obscure the underlying organic trajectory of the business — a distinction that has become increasingly relevant as investors scrutinize the quality, not just the quantity, of Brown & Brown's expansion. Its Florida concentration and exposure to middle-market commercial lines create meaningful sensitivity to regional catastrophe risk and competitive pricing cycles.


Investor Outlook

Brown & Brown, Inc. (BRO) carries a Weiss Rating of C- (Hold), reflecting a business with solid structural attributes but a near-term fundamental story that has deteriorated enough to warrant caution. Investors should watch organic revenue growth most closely — a return to positive territory excluding contingents would be the clearest sign that the business is stabilizing — along with any margin recovery commentary when the company reports next around October 26. See full rankings of all C--rated Financials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $223.67
B
AAPL NASDAQ $315.34
B
AVGO NASDAQ $364.38
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $105.83
A
Top Financial Stocks
See All »
B
B
JPM NYSE $354.71
B
V NYSE $367.39
Top Health Care Stocks
See All »
B
LLY NYSE $1,124.21
B
JNJ NYSE $267.08
B
ABBV NYSE $250.91
Top Real Estate Stocks
See All »
B
PLD NYSE $135.66
B
EQIX NASDAQ $1,043.06